Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of LRR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 334.86 | 1445 / 1445 | 100% | 14.03 | 183 / 183 |
lung | 100% | 286.21 | 578 / 578 | 100% | 13.31 | 1153 / 1155 |
breast | 100% | 339.76 | 459 / 459 | 100% | 15.27 | 1116 / 1118 |
uterus | 100% | 261.04 | 170 / 170 | 100% | 21.27 | 458 / 459 |
stomach | 100% | 250.10 | 359 / 359 | 99% | 15.52 | 284 / 286 |
intestine | 100% | 448.23 | 966 / 966 | 99% | 18.06 | 520 / 527 |
prostate | 100% | 262.25 | 245 / 245 | 98% | 7.36 | 494 / 502 |
bladder | 100% | 304.76 | 21 / 21 | 98% | 15.50 | 494 / 504 |
skin | 100% | 409.99 | 1807 / 1809 | 98% | 12.11 | 463 / 472 |
ovary | 100% | 190.81 | 180 / 180 | 98% | 9.89 | 421 / 430 |
thymus | 100% | 201.68 | 651 / 653 | 98% | 9.34 | 591 / 605 |
pancreas | 98% | 172.63 | 321 / 328 | 98% | 8.93 | 175 / 178 |
adrenal gland | 100% | 341.82 | 258 / 258 | 83% | 6.56 | 192 / 230 |
kidney | 98% | 182.26 | 87 / 89 | 82% | 4.20 | 737 / 901 |
liver | 99% | 177.05 | 224 / 226 | 78% | 5.04 | 317 / 406 |
brain | 83% | 76.90 | 2181 / 2642 | 88% | 7.54 | 620 / 705 |
adipose | 100% | 351.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.22 | 29 / 29 |
spleen | 100% | 510.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.01 | 1 / 1 |
blood vessel | 99% | 225.77 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 129.66 | 771 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 143.26 | 819 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 431.42 | 876 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 5.22 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | LRR1 |
Protein name | Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1) (LRR-1) (Peptidylprolyl isomerase-like 5) Leucine rich repeat protein 1 (Peptidylprolyl isomerase (Cyclophilin)-like 5, isoform CRA_d) Leucine rich repeat protein 1 (PPIL5 protein) |
Synonyms | hCG_1640043 PPIL5 |
Description | FUNCTION: Substrate recognition subunit of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins . ECS(LRR1) ubiquitinates MCM7 and promotes CMG replisome disassembly by VCP and chromatin extraction during S-phase (By similarity). May negatively regulate the 4-1BB-mediated signaling cascades which result in the activation of NK-kappaB and JNK1 . . |
Accessions | ENST00000554869.5 Q6P393 ENST00000298288.11 [Q96L50-1] Q96L50 ENST00000540712.1 ENST00000318317.8 [Q96L50-2] G3V5H2 |